Startups & VC
Syneron Bio closes $150 million Series B
Around April 4, Syneron Bio closed a $150 million Series B with backing from Decheng Capital, CDH VGC, Qiming, AstraZeneca, and ADIA subsidiaries.
Primary sources · 1
Around April 4, Syneron Bio closed a $150 million Series B with backing from Decheng Capital, CDH VGC, Qiming, AstraZeneca, and ADIA subsidiaries.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.